Log in  First Connection? Edition EN | FR

Latest science about Travelers' Health

Last update: Tuesday November 19, 2024

Prof. Éric CAUMES
Prof. É. CAUMES

Infectious diseases, PARIS, France

Prof. Davidson H. HAMER
Prof. D.H. HAMER

Infectious diseases, BOSTON, USA

Prof. Tomas JELINEK
Prof. T. JELINEK

Infectious diseases, BERLIN, Germany

Dr. Aisha KHATIB
Dr. A. KHATIB

Infectious diseases, TORONTO, Canada

xxx (MD, PhD)
Prof. S. HOULE

Pharmacy, WATERLOO, Canada

Global Disease Alerts for Travelers

Powered byBlueDot Logo
BlueDot Logo
BlueDot empowers organizations to identify global outbreaks that demand attention, anticipate what’s coming next, and respond appropriately. Trusted by the world’s leading public health departments, we help travelers seize every opportunity to prevent illness with timely information of critical disease risks from an unbiased source.
Experts Opinions More 

Each month, Travel Health Xpert Scientific Board offers editorials and expert opinions on the latest publications of interest in tropical diseases and travel medicine.

Epidemiology, prevention strategies, therapeutic innovations… Get access to the latest updates commented by international opinion leaders in infectious diseases!

  FOCUS HIGHLIGHTS
by Dr Emmanuel GROSS

Cholera epidemic in Mayotte and category 3 epidemiological resurgence for the WHO

In Mayotte, the cholera epidemic is gaining ground with a crisis limiting access to drinking water for several months in the archipelago. Thus, some residents are faced with poor sanitation...

Each month, Travel Health Xpert Scientific Board offers editorials and expert opinions on the latest publications of interest in tropical diseases and travel medicine.

Epidemiology, prevention strategies, therapeutic innovations… Get access to the latest updates commented by international opinion leaders in infectious diseases!

  FOCUS HIGHLIGHTS
by Dr Emmanuel GROSS

Cholera epidemic in Mayotte and category 3 epidemiological resurgence for the WHO

In Mayotte, the cholera epidemic is gaining ground with a crisis limiting access to drinking water for several months in the archipelago. Thus, some residents are faced with poor sanitation...
News More 

Editorial

Chikungunya infection: better vector control and a better understanding of this arbovirus are essential to minimize associated morbidity and mortality

by Dr Emmanuel GROSS
Chikungunya is an important disease of travelers returning from endemic areas due to its rapid geographic expansion and potential for prolonged morbidity. A better understanding of the epidemiology of travel-related chikungunya infections could influence prevention strategies, including education and vaccination. A recent study published in the "Journal of Travel Médicine", analyzing data from 1,202 travelers with chikungunya reported to GeoSentinel sites from 2005 to 2020 [1], showed that most infections were acquired in the Caribbean (28 .8%), Southeast Asia (22.8%), South Central...

Acute watery diarrhoea cases during cholera outbreak in Syria: a cohort study

Data are available upon reasonable request. The creation of a data set consisting of over 1000 patients with AWD during the 2022 cholera outbreak in Aleppo, Syria, along with detailed...
BMJ Open

Quorum regulated latent environmental cells of toxigenic Vibrio cholerae and their...

Epidemics of cholera due to infection with toxigenic Vibrio cholerae O1 continue to be a significant public health problem in many developing countries of Asia, Africa and...
Gut Pathogens

Potency, immunogenicity, and efficacy of rabies vaccine: In vitro and in vivo approach

The neurotropic rabies virus (RABV), also known as rabies lyssavirus, is the cause of rabies in both people and animals. Rabies can be spread by contact with animal saliva and, less...
Immunity, inflammation and disease

Immunogenicity and Safety of a Purified Vero Rabies Vaccine – Serum Free, Compared With...

A next-generation Vero cell rabies vaccine (PVRV-NG2) was developed using the same Pitman–Moore strain as in the licensed purified Vero cell vaccine (PVRV; Verorab®) and the...
Clinical infectious diseases
Advertisement

Search  | Advanced search

Peer-Reviewed Journals A-Z


Congress Highlights

NECTM9
NECTM9
NECTM9
The Travel Health Xpert Scientific Board is pleased to provide below the reports of
the 9th Northern European Conference on Travel Medicine (NECTM9) held from May 22 to 24 in Copenhagen, Denmark.

Everything is risky when ticks get frisky (Pfizer symposium)

Travellers grossly underestimate the risk of tick-borne diseases that are globally on the rise....

Travel and Climate Change

Global warming is occurring at a faster pace than anticipated. Greenhouse gas emissions must...

Traveller’s diarrhoea: antibiotics are used too liberal

Traveller’s diarrhoea (TD) is by far the most common health problem in travellers. Most cases...

Tick-borne diseases

Due to global warming, ticks are moving further north each year, followed by an increasing...
  More congress reports